Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Interest Coverage Ratio (2020 - 2025)

Historic Interest Coverage Ratio for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to 18.61.

  • Cytek Biosciences' Interest Coverage Ratio rose 4787.51% to 18.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 6.72, marking a year-over-year increase of 13091.28%. This contributed to the annual value of 3.92 for FY2024, which is 12913.57% up from last year.
  • According to the latest figures from Q3 2025, Cytek Biosciences' Interest Coverage Ratio is 18.61, which was up 4787.51% from 25.66 recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Interest Coverage Ratio ranged from a high of 8.8 in Q2 2021 and a low of 63.63 during Q2 2024
  • Over the past 5 years, Cytek Biosciences' median Interest Coverage Ratio value was 3.99 (recorded in 2022), while the average stood at 13.34.
  • As far as peak fluctuations go, Cytek Biosciences' Interest Coverage Ratio surged by 10403.73% in 2021, and later plummeted by 152043.39% in 2023.
  • Quarter analysis of 5 years shows Cytek Biosciences' Interest Coverage Ratio stood at 2.68 in 2021, then crashed by 95.43% to 0.12 in 2022, then tumbled by 384.38% to 0.35 in 2023, then plummeted by 44.74% to 0.5 in 2024, then crashed by 3597.15% to 18.61 in 2025.
  • Its last three reported values are 18.61 in Q3 2025, 25.66 for Q2 2025, and 51.46 during Q1 2025.